Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)

CUSIP: 74907L300

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S
Shares outstanding
9,352,472
Total 13F shares
194,151
Share change
+172,104
Total reported value
$183,220
Price per share
$0.95
Number of holders
8
Value change
+$81,697
Number of buys
8
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 74907L300?
CUSIP 74907L300 identifies QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.22%
20,968
 $100,437 — 31 Dec 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
1,063
 $5,128 — 31 Dec 2023
13F
LM Advisors LLC
13F
Company
0%
16
 $78 — 31 Dec 2023
13F

Institutional Holders of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) as of Q1 2024

As of 31 Mar 2024, Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 194,151 shares. The largest 8 holders included Altium Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, HRT FINANCIAL LP, CITADEL ADVISORS LLC, UBS Group AG, RHUMBLINE ADVISERS, and JPMORGAN CHASE & CO. This page lists 8 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
3
Q1 2024 holders
8
Holder diff
5
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .